Publication

New Therapies in Vulvar Cancer

Oonk, M. H. M. & van der Zee, A. G. J., 22-Feb-2017, Translational Advances in Gynecologic Cancers. HANLEY & BELFUS-ELSEVIER INC, p. 303-312 10 p.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Major advances have been made in vulvar cancer treatment during the last decades, exploring less morbid treatment options without compromising survival. The introduction of the sentinel lymph node procedure is one of the most important advances in surgical management of early-stage vulvar cancer patients, resulting in a significant decrease in treatment-related morbidity. Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V) II is currently investigating the safety of replacing inguinofemoral lymphadenectomy by radiotherapy in patients with a metastatic sentinel lymph node. Targeted therapy in vulvar cancer is still in its infancy; preliminary results from pilot studies are promising, however large studies are lacking. Since vulvar cancer originates by two different pathways, an human papillomavirus (HPV)-dependent and HPV-independent type, studies on targeted therapy should take this into account.

Original languageEnglish
Title of host publicationTranslational Advances in Gynecologic Cancers
PublisherHANLEY & BELFUS-ELSEVIER INC
Chapter15
Pages303-312
Number of pages10
ISBN (Electronic)9780128037980
ISBN (Print)9780128037416
Publication statusPublished - 22-Feb-2017

    Keywords

  • Angiogenesis, EGFR, HPV, Radiotherapy, Sentinel lymph node procedure, VEGF, Vulvar cancer

ID: 112110668